Health Care • Medical/Dental Instruments
$83.56 ▲ +1.71
(+2.09%)
MKT CAP: $14.22B • VOL: 1.09M
52W L $62 52W H $94
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$70
MEDIAN
$94
MEAN
$95
HIGH
$114
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE SOLV TAPE
SOLV // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $101.11 | $96.09 | 2025-02-14 | $76.04 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $105.29 | $98.60 | 2025-02-06 | $78.55 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $95.26 | $91.92 | 2025-01-29 | $80.22 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $85.23 | — | 2025-01-17 | $81.89 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $73.53 | $79.38 | 2025-01-09 | $74.37 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $99.44 | $86.90 | 2024-12-18 | $72.70 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $81.05 | $84.40 | 2024-12-04 | $77.71 | -4.3% | 48% | C |